Estimated Benefit of Dose Reduction to Highly Ventilated Lung Regions for Stage III Non-small Cell Lung Cancer Patients Using Normal Tissue Complication Probability Models

H. H. Zhang, P. Mohindra, C. B., II Simone, S. M. Bentzen, S. Senan, J. R. van Sornsen de Koste, J. Jeudy, W. D. D'Souza

Research output: Contribution to JournalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)S109-S109
JournalInternational Journal of Radiation Oncology Biology Physics
Volume99
Issue number2
Publication statusPublished - 1 Oct 2017

Cite this